Literature DB >> 31851972

Irritable Bowel Syndrome Subtypes: New Names for Old Medical Conditions.

Simona Grad1, Dan L Dumitrascu2.   

Abstract

The irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder (FGID), also called disorders of the gut-brain interaction (DGBI). Over the years, the definition and classification of IBS suffered several conceptual changes. The work of the Rome Committees has largely contributed to the progress in knowledge and awareness of IBS. This paper is an overview of the evolution of diagnosis and classification criteria of IBS. Background: The majority of the complaints causing presentation to the general gastroenterological centers are represented by FGID. IBS is the most frequent among them. IBS is not a uniform condition but includes an array of particular forms called subtypes. Criteria for the identification of the IBS subtypes have suffered several changes in parallel with the accumulation of scientific evidence about this disorder. Classification of IBS subtypes relies on symptoms. Summary: This is a review of the evolution of the criteria for diagnosis and classification of IBS subtypes. Starting with older names given to IBS, some changes in definition and diagnosis have been operated by each edition of the Rome criteria. These changes have led to the better identification of patients with IBS. The management of IBS depends on subtypes and should be individualized. Key Messages: IBS is the main FGID, called also DGBI. It is not a homogenous disorder but a generic name for an array of subtypes with common features but with clinical differences. The diagnosis and classification of IBS subtypes have evolved in time, in accordance with the progress of the knowledge on pathogenesis. It is important for healthcare providers to recognize the subtypes and to use a common nomenclature (that offered by the Rome Committees work).
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Irritable bowel syndrome; Irritable bowel syndrome subtypes; Rome criteria

Mesh:

Year:  2019        PMID: 31851972     DOI: 10.1159/000505287

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

Review 1.  How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.

Authors:  Nessmah Sultan; Jane E Varney; Emma P Halmos; Jessica R Biesiekierski; Chu K Yao; Jane G Muir; Peter R Gibson; Caroline J Tuck
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

2.  Linaclotide utilization and potential for off-label use and misuse in three European countries.

Authors:  Javier Cid-Ruzafa; Brian E Lacy; Anna Schultze; Mai Duong; Yi Lu; Mireia Raluy-Callado; Robert Donaldson; Darren Weissman; Ainhoa Gómez-Lumbreras; Dan Ouchi; Maria Giner-Soriano; Rosa Morros; Ahunna Ukah; Daniel Pohl
Journal:  Therap Adv Gastroenterol       Date:  2022-06-11       Impact factor: 4.802

Review 3.  Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?

Authors:  Vicente Martínez; Amaia Iriondo De-Hond; Francesca Borrelli; Raffaele Capasso; María Dolores Del Castillo; Raquel Abalo
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 4.  Histamine Intolerance Originates in the Gut.

Authors:  Wolfgang J Schnedl; Dietmar Enko
Journal:  Nutrients       Date:  2021-04-12       Impact factor: 5.717

Review 5.  A Systematic Review on the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in Gastrointestinal Motility Disorders: More Control, Less Risk.

Authors:  Maitri V Acharekar; Sara E Guerrero Saldivia; Sumedha Unnikrishnan; Yeny Y Chavarria; Adebisi O Akindele; Ana P Jalkh; Aziza K Eastmond; Chaitra Shetty; Syed Muhammad Hannan A Rizvi; Joudi Sharaf; Kerry-Ann D Williams; Maha Tariq; Prachi Balani
Journal:  Cureus       Date:  2022-08-04

6.  Downregulation of GRK6 in arcuate nucleus promotes chronic visceral hypersensitivity via NF-κB upregulation in adult rats with neonatal maternal deprivation.

Authors:  Xin Li; Yu-Cheng Xu; Yuan-Qin Tian; Ping-An Zhang; Shu-Fen Hu; Lin-Hui Wang; Xing-Hong Jiang; Guang-Yin Xu
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

Review 7.  Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.

Authors:  José Antonio Uranga; Vicente Martínez; Raquel Abalo
Journal:  Molecules       Date:  2020-09-20       Impact factor: 4.411

8.  Buspirone in the management of refractory irritable bowel syndrome: A case report.

Authors:  Mustafa Abdul Karim; Nadeen Al-Baz; Peter M Haddad; Shuja M Reagu; Majid Alabdulla
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.